It's important to note that these serious side effects are relatively uncommon
This is an investment that enhances both your appearance and health
doi.org/10.1002/ibd.20453 Seiwerth, S., et al
Back Braun, K, von Voss, P, Gotfredsen, CF, et al (1 Jan 2007) 'Liraglutide, a long-acting glucagon-like peptide-1 analog, reduces body weight and food intake in obese candy-fed rats, whereas a dipeptidyl peptidase-iv inhibitor, vildagliptin, does not', Diabetes , 56/1, 815
However, because long-term human data is limited, ongoing monitoring of IGF-1 levels, glucose, and overall health is strongly recommended
400+ Clinically Relevant Chapters : Each chapter within these sections is of direct clinical relevance for your daily practice